How his second time bet on Infosys didn’t work out and why getting out while the going was good turned Berger Paints into his best investment
Krishna Gopalan - September 19, 2017
One giant leap for Mankind
Mankind Pharma made it big in small towns, but can its magic help it conquer the bigger markets?
Himanshu Kakkar - January 21, 2016
Will Sun rise again?
Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?
Kripa Mahalingam - June 15, 2015
KPIT’s niche business model and attractive valuation make it a sound bet
Kripa Mahalingam - August 01, 2015
Following the good old mantra
Akhil Dhawan on his day out with Buffett
N Mahalakshmi - July 20, 2015
At Venture Intelligence’s Apex Summit, private equity experts reviewed the prospects for the sector
Kripa Mahalingam - July 13, 2015
A number of private equity investors are stuck in the middle, struggling to find profitable exits
Kripa Mahalingam - July 11, 2015